Comparison

TNFSF11 Polyclonal Antibody

Item no. E-AB-32745-60
Manufacturer Elabscience
Amount 60 uL
Quantity options 120 uL 20 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications WB, IF, ELISA
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias CD254, hRANKL2, ODF, OPGL, OPTB2, Osteoclast differentiation factor, Osteoprotegerin ligand, RANKL, Receptor activator of nuclear factor kappa B ligand, Receptor activator of nuclear factor kappa-B ligand, sOdf, TNF related activation induced cytokine, TNF-related activation-induced cytokine, TNF11, TNFSF 11, Tnfsf11, TRANCE, Tumor necrosis factor (ligand) superfamily member 11, Tumor necrosis factor ligand superfamily member 11, Tumor necrosis factor ligand superfamily member 11, soluble form
Similar products CD254, RANKL, soluble form, Tnfsf11, ODF, OPGL, OPTB2, TRANCE, hRANKL2, sOdf, TNF-related activation-induced cytokine, Tumor necrosis factor ligand superfamily member 11, Osteoclast differentiation factor, Osteoprotegerin ligand, Receptor activator of nuclear factor kappa-B ligand, Receptor activator of nuclear factor kappa B ligand, TNF related activation induced cytokine, TNF11, TNFSF 11, Tumor necrosis factor (ligand) superfamily member 11
Available
Storage Conditions
Store at -20C. Avoid freeze / thaw cycles.
Calculated Molecular Weight
35kDa
Observed Molecular Weight
40kDa
Manufacturer - Research Areas
Cancer, Cardiovascular, Immunology
Background
Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy.
Concentration
1mg/mL
Buffer
PBS with 0.02% sodium azide, 0.5% BSA and 50% glycerol pH 7.4.
Purification Method
Affinity purification
Recommended Dilution
WB 1:500-1:2000, IF 1:200-1:1000, ELISA 1:40000
Immunogen
Synthesized peptide derived from the Internal region of human RANKL

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 60 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close